Global News Get the latest news from ESTEVE on our programs and pipeline. News search engine From (dd/mm/aa) To (dd/mm/aa) SEARCH Press Releases 16/11/2021 RIEMSER BECOMES ESTEVE GERMANY WITH A NEW MANAGING DIRECTOR, KLAUS SCHWARZ Read more 18/10/2021 ESTEVE ANNOUNCES FDA APPROVAL OF A NOVEL CO-CRYSTAL FORM OF CELECOXIB AND TRAMADOL FOR THE MANAGEMENT OF ACUTE PAIN Read more 14/10/2021 FOLLOWING IN THE WAKE OF COVID-19, MYOPIA WILL BE THE NEXT PANDEMIC TO EMERGE, ESPECIALLY AMONG CHILDREN AND YOUNG PEOPLE Read more 20/07/2021 ESTEVE QUIMICA ANNOUNCES AGREEMENT WITH SEAGEN TO PRODUCE TUCATINIB (TUKYSA®) Read more READ MORE Press Kit DOWNLOAD ESTEVE social media guidelines DOWNLOAD Press Contact For more information please contact us: Olga Cajal External Communications Manager + 34 93 446 60 00 ocajal@esteve.com Press resources GO Contact ESTEVE See more About us Who we are Corporate governance Our global presence Our commitment Therapeutic areas Contract Manufacturing R&D Research Areas Pipeline Scientific publications Patients B2B Partnering Media Corporate resources Contact Adverse reactions Work with us Privacy Legal notice Cookies policy Last update 11/11/2021 | © 1996-2021 ESTEVE Use of cookies We use our own and third-party cookies for analytic, technical and profiling purposes; we process data that is needed to create profiles based on your browsing habits. Press the "ACCEPT COOKIES" button to confirm their use. You can change the configuration of your cookies by pressing "MORE INFORMATION AND CONFIGURATION". ACCEPT COOKIES MORE INFORMATION AND CONFIGURATION * *This option allows you to reject the cookies.